Federal Register / Vol. 81, No. 23 / Thursday, February 4, 2016 / Notices 6007 

DATES: 8:00 a.m.–6:00 p.m., EST, 

February 24, 2016 

ADDRESSES: CDC, Tom Harkin Global 

Communications Center, 1600 Clifton 

Road NE., Building 19, Kent ‘‘Oz’’ 

Nelson Auditorium, Atlanta, Georgia 

30329. 

Status: Open to the public, limited 

only by the space available. Time will 

be available for public comment. The 

public is welcome to submit written 

comments in advance of the meeting. 

Comments should be submitted in 

writing by email to the contact person 

listed below by February 15, 2016. All 

requests must contain the name, 

address, and organizational affiliation of 

the speaker, as well as the topic being 

addressed. Written comments should 

not exceed one single-spaced typed page 

in length and delivered in 3 minutes or 

less. Please note that the public 

comment period may end before the 

time indicated, following the last call 

for comments. Members of the public 

who wish to provide public comments 

should plan to attend the public 

comment session at the start time listed. 

Written comments received in advance 

of the meeting will be included in the 

official record of the meeting. 

The meeting will be webcast live via 

the World Wide Web; for instructions 

and more information on ACIP please 

visit the ACIP Web site: http://

www.cdc.gov/vaccines/acip/index.html. 

Purpose: The committee is charged 

with advising the Director, CDC, on the 

appropriate use of immunizing agents. 

In addition, under 42 U.S.C. 1396s, the 

committee is mandated to establish and 

periodically review and, as appropriate, 

revise the list of vaccines for 

administration to vaccine-eligible 

children through the Vaccines for 

Children (VFC) program, along with 

schedules regarding the appropriate 

periodicity, dosage, and 

contraindications applicable to the 

vaccines. Further, under provisions of 

the Affordable Care Act, at section 2713 

of the Public Health Service Act, 

immunization recommendations of the 

ACIP that have been adopted by the 

Director of the Centers for Disease 

Control and Prevention and appear on 

the CDC immunization schedules must 

be covered by applicable health plans. 

Matters for Discussion: The agenda 

will include discussions on: 

Meningococcal vaccines; human 

papillomavirus vaccines; influenza; 

hexavalent vaccine (DTaP–IPV-HibHepB); cholera vaccine; Japanese 

encephalitis vaccine; and vaccine 

supply. A recommendation vote is 

scheduled for influenza. A Vaccines for 

Children (VFC) vote is scheduled for 

hexavalent vaccine (diphtheria and 

tetanus toxoids and acellular pertussis 

adsorbed (DTaP)—inactivated polio 

vaccine (IVP)—Haemophilus influenzae 

type b (Hib)—hepatitis B (HepB). 

Agenda items are subject to change as 

priorities dictate. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, National Center for 

Immunization and Respiratory Diseases, 

CDC, 1600 Clifton Road NE., MS–A27, 

Atlanta, Georgia 30329, telephone 404– 

639–8836; Email ACIP@CDC.GOV. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2016–02080 Filed 2–3–16; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting for the initial 

review of applications in response to 

Funding Opportunity Announcement 

(FOA) PAR 15–303, Occupational Safety 

and Health Education and Research 

Centers (ERC). 

DATES: 6:00 p.m.–8:00 p.m., February 

22, 2016 (Closed) 

7:00 a.m.–6:00 p.m., February 23, 

2016 (Closed) 

7:00 a.m.–6:00 p.m., February 24, 

2016 (Closed) 

ADDRESSES: Hilton Alexandria Old 

Town, 1767 King Street, Alexandria, 

Virginia 22314, Telephone: (703) 837– 

0440. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 

552b(c)(4) and (6), Title 5 U.S.C., and 

the Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters for Discussion: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Occupational Safety and Health 

Education and Research Centers (ERC),’’ 

PAR 15–303. 

FOR FURTHER INFORMATION CONTACT: 

George Bockosh, M.S., Scientific Review 

Officer, CDC, NIOSH, 2400 Century 

Center Parkway NE., 4th Floor, Mailstop 

E–74, Atlanta, Georgia 30345, 

Telephone: (412) 386–6465, GGB0@

CDC.GOV and Donald Blackman, Ph.D., 

Scientific Review Officer, CDC, NIOSH, 

2400 Century Center Parkway NE., 4th 

Floor, Room 4204, Mailstop E–74, 

Atlanta, Georgia 30345, Telephone: 

(404) 498–6185, DYB7@CDC.GOV. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2016–02079 Filed 2–3–16; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee on Procedures Review 

(SPR), Advisory Board on Radiation 

and Worker Health, National Institute 

for Occupational Safety and Health 

Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting for the 

aforementioned subcommittee: 

DATES: 11:00 a.m.–4:30 p.m., EST, 

February 24, 2016. 

ADDRESSES: Audio Conference Call via 

FTS Conferencing. 

Status: Open to the public, but 

without a public comment period. The 

public is welcome to submit written 

comments in advance of the meeting, to 

the contact person below. Written 

comments received in advance of the 

meeting will be included in the official 

record of the meeting. The public is also 

welcome to listen to the meeting by 

joining the teleconference at the USA 


asabaliauskas on DSK5VPTVN1PROD with NOTICES